Jaguar Health (JAGX) Assets (2014 - 2026)
Jaguar Health (JAGX) reported Assets of $37.4 million for Q1 2026, down 27.26% year-over-year from $51.5 million in Q1 2025, and down 2.32% quarter-over-quarter from $38.3 million in Q4 2025.
Jaguar Health (JAGX) Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Assets data on file, last reported at $37.4 million in Q1 2026.
- Assets for Q1 2026 came in at $37.4 million, down 27.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.4 million (down 27.26% YoY), and the FY2025 annual result was $38.3 million, down 28.27% from the prior year.
- Assets declined to $37.4 million in Q1 2026 per JAGX's latest filing, from $38.3 million in the prior quarter.
- Over five years, Assets peaked at $61.5 million in Q2 2024 and troughed at $37.4 million in Q1 2026.
- A 5-year average of $50.6 million and a median of $51.3 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets increased 28.84% in 2024, then dropped 28.27% in 2025.
- A 5-year view of Assets shows it stood at $47.5 million in 2022, then climbed by 6.98% to $50.8 million in 2023, then rose by 5.24% to $53.4 million in 2024, then retreated by 28.27% to $38.3 million in 2025, then dropped by 2.32% to $37.4 million in 2026.
- Business Quant data shows JAGX's Assets at $37.4 million in Q1 2026, $38.3 million in Q4 2025, and $49.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 640.56 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 37.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.43 Mn |
| Dec 31, 2025 | 38.32 Mn |
| Sep 30, 2025 | 49.47 Mn |
| Jun 30, 2025 | 48.27 Mn |
| Mar 31, 2025 | 51.46 Mn |
| Dec 31, 2024 | 53.43 Mn |
| Sep 30, 2024 | 58.47 Mn |
| Jun 30, 2024 | 61.46 Mn |
| Mar 31, 2024 | 55.39 Mn |
| Dec 31, 2023 | 50.76 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 52.17 Mn |
| Mar 31, 2023 | 56.93 Mn |
| Dec 31, 2022 | 47.45 Mn |
| Sep 30, 2022 | 51.29 Mn |
| Jun 30, 2022 | 49.89 Mn |
| Mar 31, 2022 | 52.91 Mn |
| Dec 31, 2021 | 53.27 Mn |
| Sep 30, 2021 | 59.26 Mn |
| Jun 30, 2021 | 69.54 Mn |